| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |